UK government targets manufacturing as it eyes £41bn life science sector growth
The UK Government will enhance manufacturing and commercialisation as it looks to harness the value of the life sciences sector…
The UK Government will enhance manufacturing and commercialisation as it looks to harness the value of the life sciences sector…
GSK’s plan to bring blood cancer drug Blenrep (belantamab mafodotin) back to markets has hit a stumbling block, after the…
Hong Kong-listed Sino Biopharmaceutical will acquire China-based oncology specialist LaNova Medicines in a deal that will not exceed $951m, representing…
Danish dermatology leader LEO Pharma has bought the rights to Boehringer Ingelheim’s psoriasis drug Spevigo (spesolimab) for €90m ($105m), strengthening…
The World Health Organization (WHO) is recommending the use of Gilead Sciences’ newly approved injectable version of lenacapavir to fight…
GSK has applied to the US Food and Drug Administration (FDA) to extend use of its respiratory syncytial virus (RSV)…
Several leading medical organisations have filed a lawsuit against US health Secretary Robert F Kennedy (RFK) Jr and the US…
Johnson & Johnson (J&J) has applied to the European Medicines Agency (EMA) to extend the indication of Akeega (niraparib and…
AstraZeneca has added another indication to its blockbuster immunotherapy Imfinzi (durvalumab), gaining European approval to treat a type of bladder…
One of the biggest patent cliffs is set to hit the pharmaceutical industry this decade, with major players bracing for…